CRISPR THERAPEUTICS AG's ticker is CRSP and the CUSIP is H17182108. A total of 439 filers reported holding CRISPR THERAPEUTICS AG in Q3 2022. The put-call ratio across all filers is 0.94 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $6,494 | -59.8% | 143,067 | -50.3% | 0.01% | -52.2% |
| Q2 2023 | $16,157 | -27.9% | 287,800 | -41.9% | 0.02% | -23.3% |
| Q1 2023 | $22,394 | -30.0% | 495,103 | -37.1% | 0.03% | -31.8% |
| Q4 2022 | $31,975 | -99.9% | 786,600 | +32.6% | 0.04% | -20.0% |
| Q3 2022 | $38,772,000 | +12.2% | 593,300 | +4.3% | 0.06% | +34.1% |
| Q2 2022 | $34,560,000 | -21.6% | 568,700 | -19.0% | 0.04% | -21.2% |
| Q1 2022 | $44,083,000 | +0.5% | 702,300 | +21.3% | 0.05% | -5.5% |
| Q4 2021 | $43,865,000 | +192.4% | 578,842 | +370.2% | 0.06% | +189.5% |
| Q1 2021 | $15,001,000 | -36.0% | 123,110 | -19.6% | 0.02% | -24.0% |
| Q4 2020 | $23,456,000 | -28.9% | 153,200 | -61.2% | 0.02% | -24.2% |
| Q3 2020 | $33,013,000 | +21.9% | 394,700 | +7.1% | 0.03% | +43.5% |
| Q2 2020 | $27,093,000 | +25.5% | 368,658 | -27.6% | 0.02% | +9.5% |
| Q1 2020 | $21,594,000 | -10.1% | 509,175 | +29.0% | 0.02% | +16.7% |
| Q4 2019 | $24,031,000 | +1391.7% | 394,564 | +904.0% | 0.02% | +1700.0% |
| Q3 2019 | $1,611,000 | +394.2% | 39,300 | +244.7% | 0.00% | – |
| Q4 2018 | $326,000 | -96.8% | 11,400 | -93.3% | 0.00% | -100.0% |
| Q2 2018 | $10,054,000 | – | 171,100 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Versant Venture Management, LLC | 498,558 | $31,294,000 | 31.24% |
| NEA Management Company, LLC | 1,590,002 | $365,593,000 | 10.56% |
| Ariose Capital Management Ltd | 37,900 | $2,379,000 | 9.30% |
| ARK Investment Management | 9,404,071 | $590,294,000 | 2.46% |
| NIA IMPACT ADVISORS, LLC | 80,082 | $5,027,000 | 2.44% |
| Nikko Asset Management Americas, Inc. | 4,619,747 | $291,044,000 | 2.14% |
| PLUSTICK MANAGEMENT LLC | 50,000 | $3,139,000 | 1.98% |
| Integral Health Asset Management, LLC | 120,000 | $7,532,000 | 1.96% |
| Valiant Capital Management, L.P. | 240,683 | $15,108,000 | 1.73% |
| Deuterium Capital Management, LLC | 18,000 | $1,130,000 | 1.45% |